Skip to main content
. 2023 Mar 24;164(3):700–716. doi: 10.1016/j.chest.2023.03.024

Table 2.

Median Metrics for All MRI Parameters at Visits 1, 2, 3, and 4

MRI Parameter Visit 1 Visit 2 Visit 3 Visit 4 P Value Adjusted P Value
No. 9 9 7 8
ADC, cm2/s 0.0344 (0.309-0.0373) 0.0327 (0.0281-0.0386) 0.0340 (0.310-0.364) 0.0338 (0.307-0.0357)
LmD, μm 281 (260-300) 273 (251-301) 278 (263-290) 279 (263-288)
RBC:M 0.22 (0.15-0.37) 0.25 (0.18-0.41) 0.25 (0.19-0.44) 0.23 (0.19-0.44) V1-V2, P = .004
V1-V3, P = .047
V1-V4, P = .039
V1-V2, P = .023
V1-V3, P = .094
V1, V4, P = .094
RBC:gas 0.0026 (0.0018-0.0039) 0.0030 (0.0019-0.0038) 0.0026 (0.0020-0.0040) 0.0024 (0.0017-0.0038)
M:gas 0.0113 (0.0091-0.0125) 0.0114 (0.0081-0.0179) 0.0101 (0.0091-0.0113) 0.0094 (0.0082-0.0104) V1-V4, P = .031
V2-V4, P = .023
V3-V4, P = .031
V1-V4, P = .063
V2-V4, P = .063
V3-V4, P = .063
M T2∗, ms 2.58 (2.46-2.68) 2.47 (2.38-2.58) 2.42 (2.36-2.56) 2.22 (1.94-2.40) V1-V2, P = .044
V1-V3, P = .023
V1-V4, P = .008
V2-V4, P = .008
V3-V4, P = .031
V1-V2, P = .053
V1-V3, P = .031
V1-V4, P = .023
V2-V4, P = .023
V3-V4, P = .047
RBC T2∗, ms 2.20 (2.05-2.48) 2.16 (2.01-2.49) 2.16 (2.06-2.32) 2.27 (2.10-2.47)
DCE PBV, mL/100 mL 37.8 (11.7-53.5) 47.6 (15.0-60.2) 45.3 (36.3-58.4) 53.8 (52.46-60.72)
SD PBV, mL/100 mL 18.0 (7.5-28.5) 21.3 (13.0-24.8) 23.8 (17.9-25.7) 21.1 (20.8-22.0)
IQR PBV, mL/100 mL 25.1 (7.8-34.9) 27.8 (10.5-36.1) 35.9 (24.2-41.5) 29.5 (27.0-31.9)
DCE PBF, mL/100 mL/min 76.9 (19.6-107.2) 90.2 (30.7-109.5) 71.1 (60.3-117.7) 98.3 (93.4-116.2)
SD PBF, mL/100 mL/min 45.8 (11.5-58.8) 54.5 (32.0-75.0) 48.6 (35.6-69.5) 54.2 (41.0-65.4)
IQR PBF, mL/100 mL/min 54.0 (14.1-61.3) 59.2 (25.5-102.9) 59.0 (43.2-78.7) 64.8 (54.2-72.4)
Median MTT, s 6.5 (5.6-8.0) 7.3 (6.4-8.0) 7.1 (3.5-9.9) 6.9 (2.3 – 7.6)
SD MTT, s 1.3 (0.9-1.6) 1.2 (0.6-2.6) 1.3 (0.5-2.2) 0.7 (0.6-0.9)
IQR MTT, s 1.3 (1.1-2.0) 1.6 (0.7-3.1) 1.3 (0.6-3.5) 0.7 (0.5-1.1)
VDP, % 1.6 (0.6-3.9) 1.3 (0.7-2.6) 1.2 (0.4-2.1) 0.8 (0.4-3.7) V1-V3, P = .016 V1-V3, P = .094
Normal VP, % 76.4 (62.5-77.7) 76.9 (72.3-86.2) 78.9 (67.4-81.5) 81.1 (69.0-82.6) V1-V2, P = .027
V1-V3, P = .031
V1-V2, P = .093
V1-V3, P = .093
Low VP, % 12.5 (10.0-15.4) 11.9 (8.9-13.1) 10.9 (9.1-14.8) 10.6 (10.0-13.7)
Hyper VP, % 11.7 (9.5-18.3) 11.0 (4.2-13.3) 9.7 (7.9-15.8) 8.4 (6.8-15.2)
Lung ventilation CV, % 29.0 (27.5-37.1) 28.8 (22.3-32.2) 26.9 (25.6-34.1) 26.1 (25.0 -33.3) V1-V2, P = .040
V1-V3, P = .016
V1-V4, P = .040
V1-V2, P = .078
V1-V3, P = .078
V1-V4, P = .078

Data are presented as median (range) of all patients with available data for each visit. If a Skillings-Mack test determined that there was a significant difference between at least two variables, P values are shown for Wilcoxon pairwise tests. P values are shown prior to and following adjustment for multiple testing. ADC = apparent diffusion coefficient; CV = coefficient of variation; DCE = dynamic contrast enhanced; IQR = interquartile range; LmD = mean diffusive length scale; M = membrane; M:gas = membrane to gas fraction; MTT = mean transit time; PBF = pulmonary blood flow; PBV = pulmonary blood volume; RBC:gas = RBC to gas fraction; RBC:M = RBC to membrane fraction; T2∗ = transverse relaxation time; V = visit; VDP = ventilation defect percentage; VP = ventilation percentage.